Avid Bioservices, Inc.
CDMO · NASDAQ
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | |
|---|---|---|---|---|
| Market Cap | $482,208 | $1,105,880 | $827,575 | $1,246,242 |
| - Cash | $38,106 | $38,542 | $126,166 | $169,915 |
| + Debt | $207,834 | $189,233 | $182,525 | $118,193 |
| Enterprise Value | $651,936 | $1,256,571 | $883,934 | $1,194,520 |
| Revenue | $139,911 | $149,266 | $119,597 | $95,868 |
| % Growth | -6.3% | 24.8% | 24.8% | – |
| Gross Profit | $7,318 | $31,480 | $36,648 | $29,307 |
| % Margin | 5.2% | 21.1% | 30.6% | 30.6% |
| EBITDA | -$11,481 | $10,911 | $19,902 | $15,696 |
| % Margin | -8.2% | 7.3% | 16.6% | 16.4% |
| Net Income | -$140,753 | $560 | $127,672 | $11,212 |
| % Margin | -100.6% | 0.4% | 106.8% | 11.7% |
| EPS Diluted | -2.23 | 0.009 | 1.81 | 0.056 |
| % Growth | -25,440.9% | -99.5% | 3,143.7% | – |
| Operating Cash Flow | $10,952 | -$12,887 | $9,465 | $31,182 |
| Capital Expenditures | -$31,805 | -$77,638 | -$56,411 | -$9,864 |
| Free Cash Flow | -$20,853 | -$90,525 | -$46,946 | $21,318 |